depigold olea europea
Allergenexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2006 (NCT00396409)
Timeline
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- depigold olea europea
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01734265 | Phase 2 | Nov 1, 2012 | H. Virgen Macarena, Leti Pharma GmbH |
| NCT01591343 | Phase 2 | Jun 1, 2012 | Harrison Clinical Research, Leti Pharma GmbH |
| NCT00396409 | Phase 3 | Feb 1, 2006 | Novartis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leti Pharma GmbH | For profit | 2 | 2 | 1 | 2012 |
| Harrison Clinical Research | For profit | 1 | 0 | 1 | 2012 |
| H. Virgen Macarena | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Novartis | For profit | 1 | 1 | 1 | 2006 |
4 organizations
Page 1 / 1